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Abstract
Background: Antibiotic treatment options for common infections are diminishing due to the proliferation of
antimicrobial resistance (AMR). The impact of Antimicrobial Stewardship (AMS) programs seeking to preserve viable
antibiotic drugs by governing their use in hospitals has hitherto been limited. Pharmacists have been delegated a
critical role in antibiotic governance in AMS teams within hospitals but the experience of pharmacists in influencing
antibiotic use has received limited attention. In this study we explore the experiences of pharmacists in antibiotic
decision-making in two Australian hospitals.
Methods: We conducted 19 semi-structured interviews to explore hospital-based pharmacists’ perceptions and
experiences of antibiotic use and governance. The analysis was conducted with NVivo10 software, utilising the
framework approach.
Results: Three major themes emerged in the pharmacist interviews including (1) the responsibilities of pharmacy in
optimising antibiotic use and the interprofessional challenges therein; (2) the importance of antibiotic streamlining
and the constraints placed on pharmacists in achieving this; and (3) the potential, but often under-utilised expertise,
pharmacists bring to antibiotic optimisation.
Conclusions: Pharmacists have a critical role in AMS teams but their capacity to enact change is limited by entrenched
interprofessional dynamics. Identifying how hospital pharmacy’s antibiotic gatekeeping is embedded in the
interprofessional nature of clinical decision-making and limited by organisational environment has important
implications for the implementation of hospital policies seeking to streamline antibiotic use. Resource constraints
(i.e. time limitation and task prioritisation) in particular limit the capacity of pharmacists to overcome the interprofessional
barriers through development of stronger collaborative relationships. The results of this study suggest that to enact
change in antibiotic use in hospitals, pharmacists must be supported in their negotiations with doctors, have
increased presence on hospital wards, and must be given opportunities to pass on specialist knowledge
within multidisciplinary clinical teams.
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Background
Antimicrobial resistance (AMR) is a prominent public
health concern. While the proliferation of multi-drug
resistant pathogens reaches pandemic proportions, the
development of new antibiotic drugs has stagnated,
presenting the significant potential for a post-antibiotic
era in the near future [1–4]. The repercussions for global
health are immense, yet one of the drivers of the acceler-
ation of antibiotic resistance remains elusive to chan-
ge—the excessive and inappropriate use of antibiotics in
health service settings. Optimising antibiotic use in health-
care settings, in addition to curbing use in agriculture, is a
key domain for safeguarding antibiotics for future genera-
tions [2, 5]. In particular, studies document widespread
suboptimal prescribing in hospitals in Europe, North
America, Australasia and many OECD countries [6–8].
Research in Australian hospitals, for example, shows that
while 50 % of all inpatients receive antibiotics [9], between
20–50 % of assessable prescriptions are inappropriate [10].
The limited impact of antimicrobial stewardship (AMS)
In the past decade a range of clinical governance pro-
grams aiming at optimising antimicrobial use in hospitals
have been developed under the umbrella term of anti-
microbial stewardship (AMS) [11–16]. These initiatives
have focused largely on influencing doctors’ behaviour
given that they are the prescribers [17]. Evidence indicates,
however, that AMS programs are not achieving sustained
changes in practice either in Australia or internationally
[6, 8–10] and there is considerable uncertainty as to how
to improve clinical outcomes [18]. While there is research
emerging regarding the complex factors that influence
doctors’ antibiotic decisions [17], including institutional
norms limiting practice change [19], there has been little
examination of the experiences of non-physician stake-
holders [20, 21]. As shown in the results presented below,
hospital work is interprofessional in character and effect-
ive antibiotic governance requires a multidisciplinary
approach [11, 12, 14, 22].
The role of pharmacy in the hospital and antibiotic
governance
Traditionally the pharmacist’s role was the dispensing of
drugs at the request of the doctor [23]. In the last few
decades, pharmacy has expanded beyond dispensing med-
ications to being part of clinical teams on the hospital
wards and assuming management roles [23, 24]. Pharmacy
is an increasingly important stakeholder at the bedside
alongside nursing and medicine shifting professional focus
to pharmaceutical care and individual patients’ drug ther-
apy [25–27]. More recently, pharmacists began to assume
additional responsibilities in the governance of antibiotics
including controlling the availability of drugs in the hos-
pital [11], education and raising awareness about AMR
among nursing and medical staff [22], and providing audit
and feedback regarding antibiotic use [10, 14, 22]. How-
ever, despite these shifts it is unclear how and in what
ways pharmacists are influencing antibiotic prescribing,
directly and indirectly.1 The aim of this study is to begin
to fill this gap in knowledge by examining the experiences
of hospital pharmacists in influencing antibiotic use and
governance. In particular, we document themes in their
views on their ability to promote concordance with thera-
peutic guidelines, their relationships with doctors, and any
constraints to their participation in prescribing decisions.
Methods
Design
This is a qualitative study utilising semi-structured inter-
views with Australian hospital-based pharmacists involved
in antibiotic decision-making.
Participants and sampling
Once ethics approval was granted by The University of
Queensland and The Prince Charles Hospital Human
Research Ethics Committees (HREC #2013000029) the
study was advertised to all pharmacists working at the
two participating hospitals. Both hospitals are acute re-
gional, small to mid-size institutions with approximately
500 beds between them. They are affiliated with a
university-based clinical school providing training to up
to 20 medical students at any given time. As is required
by the Australian Commission for Safety and Quality in
Healthcare National Standards, the participating hospitals
have an active antibiotic stewardship program in place in-
cluding a post-prescription approval system for restricted
antimicrobials, with an integral role for pharmacy in
identifying restricted antimicrobial prescriptions. A multi-
disciplinary AMS committee with representation from
medical, nursing, pharmacy and executive staff meets
monthly, and is chaired by an Infectious Diseases Phys-
ician. An AMS pharmacist participates in ward rounds
twice weekly reviewing antimicrobial prescriptions. Audit
and feedback is a critical component of the AMS
programme, involving multiple specialty areas.
Over 90 % (n = 29) of the contacted pharmacists
agreed to participate. The researchers (AB and EK)
visited the hospitals on a series of scheduled days in
mid-2014, and completed interviews with all available
participant volunteers. Before the interviews, participants
received an information sheet about the study and had the
opportunity to ask questions prior to signing the consent
form. Nineteen of the pharmacists were available during
the scheduled fieldwork days. The researchers agreed
following completion and analysis of the 19 interviews
that data saturation had been reached, i.e. new data did
not offer any additional insights into the questions posed
by this study [28]. The sample included pharmacists of
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three career ‘Health Practitioner’ levels; HP3 requires a
pharmacy degree (n = 9), HP4 requires a pharmacy degree
and a post-graduate qualification (n = 7), and HP5/HP6
are management position or advanced-level practitioners
(n = 3). Pharmacists also self-reported as being “early-
career” (n = 6), “mid-career” (n = 6), or “senior” (n = 7) in
the interviews. There was as a gender split (12 females and
7 males) reflective of the hospitals’ pharmacist population.
Interview protocol
The interviews utilised a thematic guide derived from
the relevant literature and flexibly incorporated topics
raised by the participants as the interviews pro-
gressed (see Additional file 1). Such approach allowed
both systematic data collection and ongoing develop-
ment of analytical categories sensitive to the emergent
themes in the data [28, 29]. The interviews were broadly
structured around the following areas: pharmacists’
views on antibiotic use and resistance; the role of phar-
macists within the hospital regarding antibiotics; profes-
sional and interprofessional issues; and, governance and
organisational dynamics. For the purpose of this study,
we defined ‘optimal prescribing’ as the appropriate
choice of antibiotic, route of delivery and duration of
antibiotic therapy [9]. We used prompts and probes to
invite participants to reflect on antibiotic use and gov-
ernance in their hospital department. All interviews
lasted between 30 and 60 min, were audio recorded and
fully transcribed. We de-identified all references to hos-
pital locations, clinics’ names or individuals in the data
to preserve anonymity.
Data analysis
During our data analysis we continually sought to retain
the richness of the respondents’ experiences, document-
ing atypical cases, conflicts, and contradictions within
the data [30]. Upon identifying a theme we searched
through all the interviews for other related comments,
employing constant comparison to develop or complicate
them. This process helped ensure that events initially
viewed as unrelated could be grouped together as their
interconnectedness became apparent. The final step in-
volved revisiting the literature and seeking out conceptual
tools that could be employed to make sense of the
patterns that had emerged from the data [30]. NVivo10
software was used to support our thematic content ana-
lysis using the framework approach allowing comparisons
within and across cases while maintaining the analytical
complexity of the participants’ narratives [28, 31, 32].
Results
Three major themes emerged around the perceptions of
hospital pharmacy’s responsibilities in the streamlining
of antibiotics use, the constraints within which these
activities are performed and the expertise pharmacists
potentially bring to the bedside.
Professional responsibilities of pharmacy within the
hospital and antibiotic governance
All participants displayed a strong sense of professional
identity and outlined their perceptions with respect to
prescribing in both practical and general terms:
“I: What is the purpose of pharmacy?
P: It is the appropriate use of drugs, the right drug for
the right indication for the right patient, and the
right dose” (Senior, HP4).
Another participant commented on what hospital
pharmacy does:
“… tackling issues when they come up; annotating your
charts appropriately; contacting doctors when
[prescribing]’s deemed inappropriate; asking for advice
from people when you’re not sure; taking the time to
look things up if you don’t know the answer yourself.
And it’s ingrained in us through our practice from the
very beginning, this is what you’re taught […], because
that's basically what a pharmacist does is they’re a
problem solver” (Senior, HP3).
All respondents agreed that pharmacy’s main function is
to be the clinical team’s experts on medications driven by
their professional education, identity and standards. This
translates into communication with doctors, giving and
seeking advice, keeping records and establishing links across
different departments of the hospital. In everyday practice,
pharmacists assume a range of different responsibilities
when solving problems around antibiotic prescribing:
… as pharmacists we don’t make choices other than to
intervene. And our role is predominately advisory”
(Senior, HP4).
“… a hands-on approach to them, to keep on advising
and recommending and so on. Everyone has access to
the antibiotic guidelines, but it’s getting them [doctors]
to do it” (Senior, HP4).
“… It’s pretty obvious that they [doctors] aren’t aware
of the restrictions to prescribing certain antibiotics and
it’s up to pharmacy to make them aware”
(Mid-career, HP5/HP6).
Pharmacists interpreted their role in antibiotic pre-
scribing within the boundaries of their relationship with
doctors—i.e. they acted as doctors’ advisors, provided
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education and got involved more directly in antibiotic
decision-making. Hospital pharmacy’s potential to bring
drug expertise to bear is associated with its greater pene-
tration into the provision of care at the bedside. Increas-
ingly, pharmacy assumes duties beyond the dispensing
of drugs, requiring stronger involvement in clinical
practice and a physical presence on hospital wards. As
this senior pharmacist described, ideally:
“[pharmacists] spend their day … in the wards rather
than living out of a pharmacy department. … the idea
is that they’re readily available to all the doctors at
any time. … So we do act as a team, so we try and do
a little bit of everything. So at any one time one of us
could be doing anything for anyone on any ward”
(Senior, HP4).
“It’s clear if you have experienced pharmacists as part
of the team I could guarantee that would improve
antimicrobial prescribing. And that's not just for
serious things like septicaemia, that's from
everything…trained pharmacists make a huge impact,
there's just not enough, and we’re always behind the
eight ball” (Senior, HP3).
The interviews revealed environmental and resource
constraints limiting pharmacists’ ability to ensure their
clinical presence and contribute proactively to antibiotic
decisions. This perception was voiced across all levels of
seniority and areas of clinical focus. Pharmacists made
sense of these constraints and their implications for
everyday work in different ways:
“There's a basic delivery of services which needs to
happen and that is the delivery of medication, and
everything else is extra. So if you can’t, you have to
ensure that the core service is functional … until you
can cover your core work … and we’re doing it well, I
don’t see how we can then say ’well we’ll take on the
responsibility of ensuring that we do antibiotic
education, and we’re rolling out guidelines, and we’re
making sure we’re picking up suboptimal prescribing
and we’re looking at gentamicin lists and we’re doing
all the stuff that we can do to capture this problem'”
(Senior, HP4).
“… So it’s an enormous amount of work… there's a job
where you clock in and you clock out. And I think if
you’re going to be a professional maybe there's a
perception … it needs to become your vocation as well.
So that thing that you do out of hours for enjoyment
maybe that needs to be cut down a bit because you’re
going to need to put some hours in at home”
(Senior, HP3).
It emerged that pharmacy’s ongoing clinical expansion
remains somewhat incomplete. The participants expressed
an inability to work towards consistent antibiotic practices
in accordance with hospital policies during working hours.
They acknowledged new responsibilities within the tighter
governance of antibiotic use, but described a process of
prioritisation as a result of competing demands on their
time. This prioritisation revealed that a “basic delivery of
services” (i.e. the generic dispensing of drugs) was
perceived as core business with responsibilities around
promoting the judicious use of antibiotics being described
as “extras” by pharmacists on the wards. There are clear
role-based limitations on the penetration of pharmacy
expertise at the bedside and in the capacity of pharmacy
to help streamline antibiotic use.
Informal constraints on pharmacy’s antibiotic gatekeeping
practices
These constraints are made more pertinent by the
informal practices pharmacists face when attempting
to optimise antibiotic use in line with antibiotic
guidelines. Almost all of our participants talked about
difficulties to intervene once a prescription was written.
Being present at the moment of initiating antibiotic
therapy was for most the exception. This, and the
lack of a default mechanism to correct suboptimal
antibiotic scripts, exposed pharmacy interventions to
a range of inconsistencies in practice. We asked phar-
macists how they deal with prescriptions that deviate
from therapeutic guidelines:
“We cannot supply it … we all carry the list of ID
approval requirements. They’re not in the impres[t]
rooms [onsite drug supply], so then it does have to go
through pharmacy. And then pharmacy can say
'hey we’re not going to do this'. So that's our biggest
bargaining chip” (Early career, HP3).
The imprest stock is an onsite supply of medica-
tions accessible by nurses and doctors at any time.
All antibiotic drugs that need approval from an
Infectious Diseases specialist are stocked only in
limited quantity. For a supply of more than 24 h
specific dispensing from pharmacy is required for each
patient. This gives pharmacy the ability to track the use of
restricted drugs. Many of the pharmacists emphasised the
importance of this measure of control and regarded
themselves as “gatekeepers” watching over the use of
antibiotic drugs:
“… we seem to be the people that are sort of the
gatekeepers … and we seem to always be the ones
going 'well no you can’t have that. You have to get
ID approval'” (Mid-career, HP4).
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“… we have to be the gatekeeper a bit in the middle of
the nurses and the doctors. Yeah we’re very responsible
for it, if we end up with none [antibiotics] left to
choose from in the future, if we just gave everything
out willy nilly, that's the reason I guess why
everything’s not on imprest, or everything’s not in the
after hours cupboard, because there's meant to be a
pharmacist involved in that” (Early career, HP3).
“… We can then go and say ‘okay we’ve now got thirty
patients, we’ll look at charts to see how inappropriate
prescribing is. Let’s see the areas or the teams or who
are prescribing inappropriately.’ We then need to
feedback to them to say ‘look there's a problem here.
These are actually the guidelines, this is what we need
to do. Would you like some assistance in writing a
protocol? Do you need education?’” (Senior, HP4).
Managing and restricting the supply of antibiotic drugs
is one of the key antimicrobial stewardship interventions
of hospital pharmacy. Pharmacists justified this enact-
ment of interprofessional control emphasising their re-
sponsibility to safeguard the viability of antibiotics for
the future. The latter interview excerpt above demon-
strates how restrictive management of supply is accom-
panied by attempts to educate and raise awareness about
therapeutic guidelines. Participants also discussed the
limitations a restrictive approach to streamlining anti-
biotic use imposes. The same participant as above ad-
mitted that:
“… pharmacy can certainly be a platform because they
have the ability to restrict the actual supply. And
that's not necessarily the right answer…” (Senior, HP4)
“… there isn’t enough time obviously for pharmacy to
both review it and supply it. So it’s hard. You’re
talking about a system that has to still function.
How much do you restrict it? How much can you
restrict it?” (Early career, HP3).
The participants doubted that gatekeeping practices
alone were the best way to optimise antibiotic use.
The latter interviewee above viewed it even as poten-
tially harmful to “the functioning of the system”. This
argument relates to the hospital as an organisational
setting characterised by hierarchically-structured pro-
fessional relations. Establishing a dispensing authority
in the form of the pharmacist as gatekeeper alongside
the prescribing authority manifest in the doctor was
perceived as a threat to the integrity of that system.
The majority of participants voiced concerns about
the appropriateness and effectiveness of this part of
their work:
“So it depends on the ward, whether it’s on the
impres[t], like in their drug rooms. Then the nurses
just have the straight out availability to go and take it.
… If a pharmacist doesn’t see it it can just go under
the radar. … also, if they don’t have it on their ward they
will go to another, the respiratory ward that does have it
and get it just to avoid pharmacy” (Early career, HP3).
“… they’ll just go to a different ward, or they’ll change
it to something easier that someone's not going to
hassle them about, but might not be the best choice. I
think that's a big problem is a lot of the time they will
do something easier, that doesn’t require ID [Infectious
Diseases approval] … they’ll choose a different
antibiotic rather than choosing the correct one and
just giving them a call” (Early career, HP3).
Restrictive supply management on its own was de-
scribed by the above, and other participants as ultimately
counterproductive and encouraging suboptimal choice
of antibiotic drug rather than providing decision aids for
problematic cases. These reported informal practices
undermined these pharmacists’ capacity to enforce best
practice guidelines and put pressure on them to engage
directly with doctors in discussions about appropriate
antibiotic prescribing. These negotiations take place
between distinct professional communities drawing on dif-
ferent types of knowledge resources, cultural idiosyncrasies
and sets of responsibilities.
Pharmacy’s antibiotic expertise at the bedside
Gatekeeping practices alone are ineffective and may have
adverse effects on the choice of antibiotics pushing
pharmacy to intervene more directly in the prescribing
process. Participants’ accounts of their involvement
expanded beyond the choice of drug into common
prescribing issues around duration, dosage and mode of
delivery. While some pharmacists dismissed doctors as
“ignorant” or even “lazy”, others explained suboptimal
prescribing practices in terms of different knowledge
resources, professional standards, localised norms and dif-
fering notions of care, i.e. pharmaceutical care as narrowly
focused on individual drug therapy and clinical care as
taking a holistic approach to patient assessment and treat-
ment. More precisely they perceived it as a clash between
medical judgment and pharmaceutical standards. The
following participants discussed how they view pharmacy’s
drug expertise fitting into clinical practice:
“… for us [pharmacy] our main focus all the time is drugs.
And I'm aware that for the doctors, they’ve got so many
other things that they have to think about. And so
sometimes for them they’ve just got to get whatever it is
written down and look at everything else” (Mid-career, HP4).
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“… We’re pharmacy based so we’re thinking about
drugs all the time … Whereas they [doctors]’ve got a
much broader spectrum. … we’re pretty privileged as
being pharmacists in hospitals that we get to look at
the holistic view of the patient, we are able to look at
their labs, we can see their sensitivities, … we’ve had
four-and-a-half … years training looking at medica-
tions and seeing if they’re appropriate. And then we
can relay that to the doctors” (Early career, HP3).
The pharmacists understood their expertise as
unique and highly specialised on drugs as opposed to
the broader remit of medical knowledge. They framed
this expertise as different from, and more specialised
than, the clinical knowledge of the medical profession.
Most participants agreed that the value of pharmacy
is not to supplant medical judgment but provide
practical advice and prompts to complement it, for
example, by assisting with precise dosing, raising aware-
ness about AMR and promoting the accessibility of
clinical guidelines. Pharmacists built on their professional
education and standards to argue for their potential to
make meaningful contributions in the clinical field. They
situated their argument within an ethical discourse about
the “patient good” which served as an overarching frame-
work connecting pharmacy with the medical profession.
This subtheme became more evident when they talked
about the frustrations they experience when their drug
expertise clashed with prescribing decisions made by
doctors:
“… if [as a doctor] you've seen something prescribed
over ten years and you know it’s going to work you
know, it might be 90 % right. … You can go up to a
doctor and go ‘why did you choose this’ or whatever,
and it’s like’close enough is good enough’, … As long as
they’ve got something that's treating the patient and
they’re going to get better, then I don’t think they care
too much” (Mid-career, HP4).
“Well close enough is not good enough! … ‘I think the
dose is okay, it won’t kill them, it’ll do’, that's terrible,
that is absolutely terrible. … we’re in an electronic age,
it’s at your fingertips, it’s not that hard to look up. …
I would no sooner prescribe something that I wasn't
completely sure what the dose was, if I could prescribe,
than fly to the moon! You know that's terrible! It’s a
patient!” (Mid-career, HP4).
“… you see it all the time and you go’that's not great but
it’s safe, it’s a little bit effective’ and … you've got to pick
your battles … we’re still often giving supply because
it’s either the patient gets no antibiotics, or a patient
gets something that - you know we can sort of look
from our end I guess and say ’yeah they’re covering
the right bug, it’s probably not the best therapy’”
(Early career, HP3).
There was a high degree of inconsistency within the
interviews regarding how the participants resolved the
tension between their drug expertise and allowing for
medical judgment and thus reducing conflict. Individual
pharmacists make choices to what extent they follow-up
cases of suboptimal prescribing. While some argued
prescribing is either done right or wrong and deviations
from best practice were challenged, others engaged in
“picking battles” and perceived antibiotic prescribing as
a grey zone. The first group of participants drew on
collective quality standards within the pharmacy profes-
sion to enforce precise dosing, appropriate choice of
drug, duration and mode of delivery. They supported
their argumentation by pointing out the instant availabil-
ity of knowledge resources online and off-line, laboratory
testing with short turnarounds and pharmacy and ID
counsel. Ultimately, they utilised discourses about the
“patient good” to justify demands on the medical profes-
sion for greater accuracy in antibiotic prescribing. The
second group engaged in a process of prioritisation and
de-escalation guided by pragmatic principles taking into
account resource constraints of time-poor doctors, the
multitude of clinical factors doctors have to consider
beyond drugs and the apparent—albeit limited—efficacy
of the course of antibiotic treatment. They also drew on
similarly understood discourses about the “patient good”
to defend poor prescribing as long as patient outcomes
were positive. Both groups placed short-term patient
outcomes rather than long-term concerns about AMR at
the centre of their ethical reasoning moderating the
moral distress of sub-optimal antibiotic practices [33]. In
either group ideas about the “patient good” were used to
bridge the professional gap between pharmaceutical and
medical care and implicitly confirm pharmacy’s legitim-
ate presence at the bedside.
Discussion
The proliferation of AMR has resulted in attempts to
better govern the use of antibiotics in hospitals. However,
recent changes to antibiotic governance with a focus on
altering doctors’ behaviour have had limited success. Our
previous research revealed the significance of other stake-
holders in antibiotic decision-making [17], and a variety of
AMS approaches acknowledge, in particular pharmacists’
potential to make a meaningful contribution to streamlin-
ing antibiotics use [11, 12, 14, 20]. This study reveals three
important insights into hospital-based pharmacists’ expe-
riences of antibiotic prescribing.
First, this study indicates that hospital pharmacists
perceive themselves as antibiotic gatekeepers seeking to
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fulfil educational, advisory and supervisory roles within
antibiotic governance—they negotiate with other stake-
holders caring for patients at the bedside to bring their
expertise on drugs to bear and are empowered by their
control over the supply of antibiotics. This reaffirms the
interprofessional nature of antibiotic decision-making
and the need to address potential institutional and infor-
mal barriers to enhanced collaboration across profes-
sionals and settings in the hospital.
Second, we found that some doctors and nurses can
undermine pharmacists’ dispensing of restricted antibiotic
drugs, thus weakening their ability to prevent deviations
from therapeutic guidelines and offer timely advice on
drug choice, mode of delivery and duration. This high-
lights the potential detrimental effects of interprofessional
dynamics and resource constraints on hospital pharmacy‘s
capacity to perform responsibilities pertaining to antibiotic
governance. Increased presence on the hospital wards
and better integration into clinical teams would
provide more opportunities to pharmacists to get in-
volved in antibiotic decision-making, ideally prior to
prescriptions being written.
Third, consistent with previous research on the report-
ing of prescribing errors [34], pharmacists in our sample
dealt inconsistently with suboptimal antibiotic prescrip-
tions brought to their attention. The individual pharma-
cists reported that they made choices about when to
intervene and seek to correct or optimise antibiotic
treatment decisions. Some stressed the importance of con-
cordance with therapeutic guidelines and pharmaceutical
best practice whereas others strategically challenged
inaccuracies in antibiotic prescribing, and selectively so.
However, this study is not without limitations. Given
the qualitative approach of the study, the findings within
this context cannot be generalized to other settings. The
AMS program implemented at the participating hospitals
favours, besides educational measures and evaluation, the
restrictive management of antimicrobials through its anti-
biotic approval system in which pharmacy is tasked with
gatekeeping duties. Pharmacists working in settings with
no antibiotic restrictions, or with AMS programs which
rely on other mechanisms may encounter different issues.
Our data indicated that there exists a tension between
clinical judgment and pharmaceutical expertise which
requires significant exploration. Only if the reasoning
behind pharmacists’ decisions to prioritise and intervene
in the optimisation of antibiotics use and its relation to
medical expertise is understood, institutional mechanisms
can be designed to promote more consistent engagement
of hospital pharmacy in antibiotic governance.
Conclusions
Our findings have significant repercussions for antibiotic
optimisation and streamlining. The increasing self-
perception of pharmacy as antibiotic gatekeeper opens
up significant potential for individual pharmacists to in-
fluence antibiotic decision-making in everyday practice.
However, the resistance of doctors to pharmacy advice
and the inconsistencies in pharmacy practice impose
severe constraints on the implementation of hospital
policies aiming at the optimisation of antibiotic prescrib-
ing. These need to be addressed, for example via the
design of institutional mechanisms that are sensitive to
the differences in professional culture and provide
pharmacy with a stronger foothold at the bedside. This
includes the reallocation of resources to acknowledge
hospital pharmacy’s responsibilities beyond the dispens-
ing of medicines and provide them with opportunities to
accumulate specialised clinical experience. Increased
presence of pharmacists on hospital wards across high
resource and low resource settings would also allow the
establishment and maintenance of trusting relationships
between pharmacists and doctors that promotes a sense
of shared obligation to the “patient good” and a mutual
understanding as partners in the effort to curb the
proliferation of AMR.
Endnote
1In Australia, for example, the automatic stop order
system allows them to effectively nullify antibiotic treat-
ment decisions made by doctors if these are in violation of
institutional procedures, such as lacking timely approval
of restricted drugs by an Infectious Diseases specialist.
Little is known however, to what extent pharmacists
exercise this measure of control in practice.
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